Chronic Myelomonocytic Leukemia

Chronic Myelomonocytic Leukemia (CMML) is a rare type of blood cancer that affects your bone marrow, the soft tissue inside your bones where blood cells are made. In CMML, your bone marrow produces too many abnormal white blood cells called monocytes. At the same time, it can struggle to make enough healthy red blood cells, platelets, and other types of white blood cells. This condition is considered "chronic" because it typically develops and progresses slowly over time, making it a unique condition with features of both myelodysplastic syndromes and myeloproliferative neoplasms. CMML usually develops when there are acquired changes, or mutations, in the DNA of a single stem cell in your bone marrow. These genetic changes are generally not inherited but occur randomly during a person's lifetime and are more common in older adults, typically affecting individuals over 60. While specific causes are often unknown, factors like previous cancer treatments can sometimes play a role, but most cases arise without a clear identifiable cause. To diagnose CMML and understand its specific characteristics, various lab tests are essential. These tests, including blood counts (like your Complete Blood Count or CBC), blood smears to examine cell appearance, and often a bone marrow biopsy, help your doctors identify the abnormally high number of monocytes and assess the health of your other blood cells. They also look for specific genetic markers that confirm the diagnosis, help determine the subtype of CMML, and guide the most effective treatment plan for you. Regular monitoring through these tests is crucial for managing the condition and tracking its progress.